1. Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy
   Katerina Vavrova et al, 2016, Med Oncol CrossRef
2. Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
   Kristian M. Hargadon, 2017, Front. Immunol. CrossRef
3. High hydrostatic pressure in cancer immunotherapy and biomedicine
   Irena Adkins et al, 2018, Biotechnology Advances CrossRef
4. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
   Barbara Montico et al, 2018, IJMS CrossRef
5. Immune response effects of diverse vaccine antigen attachment ways based on the self-made nanoemulsion adjuvant in systemic MRSA infection
   Liu-yang Yang et al, 2018, RSC Adv. CrossRef
6. Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens
   Francesco De Sanctis et al, 2018, Vaccine CrossRef
7. High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy
   Linda Urbanova et al, 2017, Immunology Letters CrossRef
8. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
   Silvia Martin Lluesma et al, 2018, Vaccines CrossRef
9. Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
   Alfonso Serrano-del Valle et al, 2019, Front. Cell Dev. Biol. CrossRef
10. Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment
    Christoph Seitz et al, 2019, Front. Oncol. CrossRef
11. null
    I. Truxova et al, 2017 CrossRef
12. Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
    Nada Hradilova et al, 2017, PLoS ONE CrossRef
13. The evolution of chemotherapy for the treatment of prostate cancer.
    D I Quinn et al, 2017, Ann Oncol CrossRef
14. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice
    Romana Mikyskova et al, 2017, OncoImmunology CrossRef
15. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases
    Benjamin Frey et al, 2017, Immunol Rev CrossRef
16. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer
    Jitka Fucikova et al, 2018, Immunology Letters CrossRef
17. null
    Wendy Mao et al, 2018 CrossRef
18. Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
    Jitka Fucikova et al, 2019, Front. Immunol. CrossRef
19. Low-dose docetaxel enhances the anti-tumour efficacy of a human umbilical vein endothelial cell vaccine
    Ling Zhou et al, 2019, European Journal of Pharmaceutical Sciences CrossRef
20. Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: correlation of the quality of T cell responses with NSCLC subtype
    Palata Ondrej et al, 2020, Immunology Letters CrossRef
21. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
    María Julia Lamberti et al, 2020, Pharmaceutics CrossRef
22. Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines
    Jana Simova et al, 2016, Oncotarget CrossRef
23. Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists
    Célia Jacoberger-Foissac et al, 2020, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
24. Distinct phenotypes and ‘bystander’ effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines
    Olena Sapega et al, 2018, Int J Oncol CrossRef
25. Antitumour dendritic cell vaccination in a priming and boosting approach
    Alexandre Harari et al, 2020, Nat Rev Drug Discov CrossRef
26. Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition
    Patrik Oleksak et al, 2021, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
27. WHSC1/NSD2 regulates immune infiltration in prostate cancer
    Muzamil Y Want et al, 2021, J Immunother Cancer CrossRef
28. Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
    Claudia Maletzki et al, 2023, Cell Death Discov. CrossRef